Ligand validation:9VPV

ORO: OROTIC ACID

ORO is a Ligand Of Interest in 9VPV designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9VPV_ORO_C_402	96%	7%	0.057	0.965	1.46	3.34	2	3	0	0	100%	1
9VPV_ORO_A_402	91%	7%	0.068	0.956	1.5	3.35	2	3	0	0	100%	1
9VPV_ORO_D_402	80%	7%	0.085	0.934	1.5	3.38	2	3	0	0	100%	1
9VPV_ORO_B_402	76%	6%	0.087	0.922	1.5	3.44	2	3	0	0	100%	1
9VQ0_ORO_C_403	92%	6%	0.058	0.949	1.75	3.38	3	2	0	0	100%	1
2B4G_ORO_D_4399	91%	25%	0.08	0.967	1.19	1.83	-	2	0	0	100%	1
9VPW_ORO_D_402	66%	6%	0.098	0.903	1.61	3.41	3	4	1	0	100%	0.81
9CCC_ORO_A_401	100%	1%	0.02	0.997	2.22	6.22	3	4	0	0	100%	1
9DHH_ORO_A_402	100%	8%	0.025	0.992	1.58	3.05	2	2	0	0	100%	1
6FMD_ORO_A_411	100%	9%	0.034	0.992	1.02	3.42	1	2	0	0	100%	1
9DHI_ORO_A_402	100%	0%	0.032	0.99	2.36	6.63	2	4	0	0	100%	1
9DHJ_ORO_A_402	100%	1%	0.033	0.989	2.35	6.35	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.